- FREE CONSULTATION & SHIPPING
- NEWEST WEIGHT LOSS PEPTIDE: RETATRUTIDE
- A NEW ERA OF HEALTH, BORN IN THE PHILIPPINES
- FREE CONSULTATION & SHIPPING
- NEWEST WEIGHT LOSS PEPTIDE: RETATRUTIDE
- A NEW ERA OF HEALTH, BORN IN THE PHILIPPINES
Neuropeptide (ACTH Fragment) · Educational Resource
Understanding Semax and Cognitive Research
Synthetic ACTH(4-10) Analog
(Heptapeptide)
Investigational Application
Neuroprotection, cognitive focus research
Administration Protocol
Intranasal, per study protocol
Want to learn more?
A licensed team will reach out to guide you through the research.
Book a consultation →Neuropeptide (ACTH Fragment) · Educational Resource
Understanding Semax and Cognitive Research
01 — Overview
What is Semax?
Semax is a synthetic heptapeptide, structurally derived from a fragment of adrenocorticotropic hormone (ACTH), studied for its relationship to neuroprotective and cognitive research.
Semax holds approved status in Russia and some other countries for specific neurological indications, while remaining an investigational compound without regulatory approval in the Philippines and many other jurisdictions.
Within research literature, Semax is most frequently studied for its relationship to BDNF expression and cognitive focus parameters, areas summarized further below.
02 — How it works
How It Works: BDNF Modulation and Neuroprotective Signaling
As an ACTH(4-10) fragment analog, Semax is studied for its ability to modulate brain-derived neurotrophic factor (BDNF) expression, a protein researchers associate with neuronal survival and synaptic plasticity.
Literature also describes Semax's studied interaction with neurotransmitter systems relevant to attention and stress response, distinguishing it from hormone-replacement or metabolic-pathway compounds.
Administration in Research
In clinical literature, primarily from countries where Semax holds approved status, it is evaluated as an intranasal spray administered within controlled research or clinical protocols. In the Philippines, it remains an investigational compound, and research contexts differ from any at-home or self-directed use.
03 — Areas of research
Summary of Investigated Research Areas
Clinical and preclinical literature evaluates Semax across several key physiological parameters to map its biological interactions:
BDNF Expression Pathways
Research literature evaluates how Semax is studied for its relationship to brain-derived neurotrophic factor (BDNF) expression in preclinical models.
Cognitive Focus Studies
Clinical studies observe attention and focus-related measures following Semax administration in research settings.
Neuroprotective Markers
Investigational literature examines neuroprotective markers associated with Semax exposure during induced ischemic events in preclinical models.
Cerebral Blood Flow Parameters
Studies explore cerebral blood flow changes associated with Semax administration in clinical research.
Stress Response Studies
Some literature investigates Semax's studied relationship to stress-response hormone pathways.
Pharmacokinetic Profiling
Studies characterize the absorption profile of intranasal Semax in clinical research.
04 — FAQ
Frequently Asked Questions
Ano ba talaga ang Semax?
Ang Semax ay isang synthetic heptapeptide na hango mula sa ACTH hormone fragment. Pinag-aaralan ito sa research dahil sa posibleng papel nito sa neuroprotection at cognitive focus. Educational discussion lang ito, hindi sales o medical advice.
FDA-approved ba ito?
May approved status ito sa Russia at ilang bansa para sa partikular na neurological indications, ngunit hindi pa ito approved sa Pilipinas — dapat itong tratuhin bilang investigational compound dito.
Paano ito ibinibigay sa research?
Sa literature, karaniwang ginagamit ang intranasal (spray sa ilong) na paraan ng pagbibigay sa mga klinikal at research settings.
Pwede ba akong bumili nito dito?
Ang page na ito ay para sa educational purposes lamang. Hindi kami nagbebenta ng peptides dito online — kausapin ang isang lisensyadong healthcare provider para sa tamang gabay.
05 — References
References and Academic Literature
Gusev, E.I., et al. (2005). Effectiveness of Semax in Acute Period of Hemispheric Ischemic Stroke. Zhurnal Nevrologii i Psikhiatrii.
Shadrina, M.I., et al. (2001). Effects of Semax on Neurotrophin Gene Expression in the Rat Brain. Bulletin of Experimental Biology and Medicine.
Kaplan, A.Y., et al. (1996). Synthetic ACTH Analogue Semax Displays Nootropic-Like Activity in Humans. Neuroscience Research Communications.
i
Medical Education Disclaimer: This page is intended strictly for educational and informational purposes regarding the scientific history and development of chemical compounds. It does not constitute medical advice, promotion, or advertising of any prescription medication. Any therapeutic applications must be evaluated and managed exclusively by a licensed medical practitioner.
Getting started
How to Get Started?
1. Consult
Book a free consultation with our licensed healthcare team.
100 % online. Hassle-free. Convenient.
2. Real Human Assessment
Talk with Philippine-licensed doctors and get prescribed.
Always doctor-led—never just an online form.
Free consultation with licensed providers
3. Start your Program
Your medication is prepared and delivered to your doorstep.
No lock-ins. No hidden fees. No subscriptions.
Formulated in FDA-regulated pharmacies
4. Consistent care
Stay on track with regular weekly follow-ups. On your chosen communication platform.
Unlimited complementary follow-ups